Clinical trial
Directional AthErectomy Followed by a PaclItaxel-Coated BalloN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment - Two Year Follow-up Extension Study
NCT02363894 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Directional AthErectomy Followed by a PaclItaxel-Coated BalloN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment - Two Year Follow-up Extension Study
- Lead sponsor
- Medtronic Endovascular
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- June 30, 2015
- Enrollment
- 53 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.